Clinical trial

Mechanistic Insights to Weight Loss Maintenance Through SGLT2 Inhibitors

NCT05885074

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2025-01-30

PhasePHASE2

Study timeline

Study start (estimated)2025-01-30Date precision: day

Registry last updated2024-08-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Weight Lossunresolved

Interventions

Empagliflozin ArmDRUG

Control ArmOTHER

Exercise capacity VO2 maximum determinationOTHER

Exercise ChallengeOTHER

Sponsors & collaborators

University of Alabama at Birminghamlead sponsor

Mapped research locations

BirminghamAlabama, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05885074 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.